Two separate human clinical trials (ulcerative colitis and multiple sclerosis) proceeded without significant adverse event reporting
There are several reasons why this happens
Microdosing involves the off-label use of GLP-1 medications (semaglutide and tirzepatide) at much smaller doses than the standard recommended dose, such as: Consuming a fraction of a starter dose, such as 0.05 mg of Ozempic instead of 0.25 mg
Environment International 34(1): 139153
Addressing insulin resistance is crucial in the context of obesity, given its key contribution to the onset of numerous chronic conditions, including T2D, atherosclerosis, non-alcoholic fatty liver disease (NAFLD), and polycystic ovary syndrome (PCOS), among others [14]
versions: 0.25 mg, 0.5 mg, 1 mg, 2 mg pens Available in retail pharmacies and through diabetes clinics Country Comparison United States vs